The FTC report showed that from 2017 to 2022, the three PBMs—UnitedHealthGroup's Optum, CVSHealth's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by ...
Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends CVSHealth and UnitedHealthGroup. The Motley Fool has a disclosure policy.